Commentary on "Intrauterine perfusion of dexamethasone improves pregnancy outcomes in recurrent reproductive failure patients with elevated uterine natural killer cells"
American Journal of Reproductive Immunology · 2024
DOI: 10.1111/aji.13862 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Reproductive Immunology, 2024. Verfasst von Junwu Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Dexamethasone, Killer Cells, Natural, Uterus, Pregnancy Outcome. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, China.
- Department of Gynecology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, China.
ORCID-Profile: Junwu Zhang
Zitieren
APA
Zhang, J., & Sun, Y. (2024). Commentary on "Intrauterine perfusion of dexamethasone improves pregnancy outcomes in recurrent reproductive failure patients with elevated uterine natural killer cells". American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13862
Vancouver
Zhang J, Sun Y. Commentary on "Intrauterine perfusion of dexamethasone improves pregnancy outcomes in recurrent reproductive failure patients with elevated uterine natural killer cells". American Journal of Reproductive Immunology. 2024. doi:10.1111/aji.13862
BibTeX
@article{Zhang2024,
author = {Zhang, Junwu and Sun, Yun},
title = {Commentary on "Intrauterine perfusion of dexamethasone improves pregnancy outcomes in recurrent reproductive failure patients with elevated uterine natural killer cells"},
journal = {American Journal of Reproductive Immunology},
year = {2024},
doi = {10.1111/aji.13862}
}
EUVIMED